Summary
Amendment to the Diagnostic Imaging Services Table under the Health Insurance Act, governing Medicare benefits for diagnostic imaging procedures. Sets scheduled fees, item numbers, and eligibility criteria for various imaging services (X-rays, MRIs, ultrasounds, etc.) that qualify for government rebates.
Reason
Government-controlled pricing and service listings for diagnostic imaging create artificial scarcity, reduce competition, and distort market signals. Providers must navigate bureaucratic item numbers and compliance requirements, while the fee schedule suppresses price competition that would otherwise drive innovation and access. This central planning approach inevitably leads to rationing, reduced supply (especially in rural areas), and slower adoption of new technologies. Australians would benefit from liberalizing the sector—allowing providers to set prices freely and eliminating Medicare's gatekeeping role would increase choice, lower costs through competition, and accelerate innovation in diagnostic services.